News & Events
24th January 2020
Saluda Medical Highlights Multiple Presentations Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System at NANS Annual Meeting
21st December 2019
Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology
13th December 2019
See us at NANS 23rd - 26th Jan 2020
16th September 2019
Saluda Medical Announces European Commercial Launch of Evoke®, the First and Only ECAP-Controlled, Closed-Loop SCS System for Chronic Pain Relief
28th June 2019
Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
27th June 2019
Saluda Medical Secures Debt Financing From Medtronic
3rd June 2019
Saluda Medical Announces Clinical Study Results for Evoke® ECAP-Controlled, Closed-Loop SCS System for the Treatment of Chronic Pain
20th May 2019
Saluda Medical Announces New 3-Month, 12-Month and 18-Month Data Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System to be Presented at 14th INS World Congress
13th October 2016
Saluda Patients Featured on Australian National News
13th July 2016
Saluda Medical Featured in Nature
13th December 2019
See us at NANS 23rd - 26th Jan 2020
24th January 2020
Saluda Medical Highlights Multiple Presentations Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System at NANS Annual Meeting
21st December 2019
Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology
16th September 2019
Saluda Medical Announces European Commercial Launch of Evoke®, the First and Only ECAP-Controlled, Closed-Loop SCS System for Chronic Pain Relief
28th June 2019
Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
27th June 2019
Saluda Medical Secures Debt Financing From Medtronic
3rd June 2019
Saluda Medical Announces Clinical Study Results for Evoke® ECAP-Controlled, Closed-Loop SCS System for the Treatment of Chronic Pain
20th May 2019
Saluda Medical Announces New 3-Month, 12-Month and 18-Month Data Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System to be Presented at 14th INS World Congress
30th May 2017
Saluda Medical Secures AU $53 Million in Series D Financing